tetano
Editor, Senior Moderator
Int J Biol Macromol
. 2024 Jun 5:132901.
doi: 10.1016/j.ijbiomac.2024.132901. Online ahead of print. N-glycosylation on hemagglutinin head reveals inter-branch antigenic variability of avian influenza virus H5-subtypes
Keyi Shi[SUP] 1 [/SUP], Saixiang Feng[SUP] 1 [/SUP], Li Zhao[SUP] 1 [/SUP], Junhong Chen[SUP] 1 [/SUP], Wei Song[SUP] 1 [/SUP], Yusheng Jia[SUP] 1 [/SUP], Xiaoyun Qu[SUP] 1 [/SUP], Zhicheng Liu[SUP] 2 [/SUP], Weixin Jia[SUP] 3 [/SUP], Shouwen Du[SUP] 4 [/SUP], Ming Liao[SUP] 5 [/SUP]
Affiliations
H5-subtype avian influenza virus (AIV) is globally prevalent and undergoes frequent antigenic drift, necessitating regular updates to vaccines. One of the many influencing elements that cause incompatibility between vaccinations and epidemic strains is the dynamic alteration of glycosylation sites. However, the biological significance of N-glycosylation in the viral evolution and antigenic changes is unclear. Here, we performed a systematic analysis of glycosylation sites on the HA1 subunit of H5N1, providing insights into the changes of primary glycosylation sites, including 140 N, 156 N, and 170 N within the antigenic epitopes of HA1 protein. Multiple recombinant viruses were then generated based on HA genes of historical vaccine strains and deactivated for immunizing SPF chickens. Inactivated recombinant strains showed relatively closer antigenicity compared to which has identical N-glycosylation patterns. The N-glycosylation modification discrepancy highlights the inter-branch antigenic diversity of H5-subtype viruses in avian influenza and serves as a vital foundation for improving vaccination tactics.
Keywords: Antigenicity of hemagglutinin; H5-subtype AIV; N-glycosylation.
. 2024 Jun 5:132901.
doi: 10.1016/j.ijbiomac.2024.132901. Online ahead of print. N-glycosylation on hemagglutinin head reveals inter-branch antigenic variability of avian influenza virus H5-subtypes
Keyi Shi[SUP] 1 [/SUP], Saixiang Feng[SUP] 1 [/SUP], Li Zhao[SUP] 1 [/SUP], Junhong Chen[SUP] 1 [/SUP], Wei Song[SUP] 1 [/SUP], Yusheng Jia[SUP] 1 [/SUP], Xiaoyun Qu[SUP] 1 [/SUP], Zhicheng Liu[SUP] 2 [/SUP], Weixin Jia[SUP] 3 [/SUP], Shouwen Du[SUP] 4 [/SUP], Ming Liao[SUP] 5 [/SUP]
Affiliations
- PMID: 38848854
- DOI: 10.1016/j.ijbiomac.2024.132901
H5-subtype avian influenza virus (AIV) is globally prevalent and undergoes frequent antigenic drift, necessitating regular updates to vaccines. One of the many influencing elements that cause incompatibility between vaccinations and epidemic strains is the dynamic alteration of glycosylation sites. However, the biological significance of N-glycosylation in the viral evolution and antigenic changes is unclear. Here, we performed a systematic analysis of glycosylation sites on the HA1 subunit of H5N1, providing insights into the changes of primary glycosylation sites, including 140 N, 156 N, and 170 N within the antigenic epitopes of HA1 protein. Multiple recombinant viruses were then generated based on HA genes of historical vaccine strains and deactivated for immunizing SPF chickens. Inactivated recombinant strains showed relatively closer antigenicity compared to which has identical N-glycosylation patterns. The N-glycosylation modification discrepancy highlights the inter-branch antigenic diversity of H5-subtype viruses in avian influenza and serves as a vital foundation for improving vaccination tactics.
Keywords: Antigenicity of hemagglutinin; H5-subtype AIV; N-glycosylation.